JPWO2022005807A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022005807A5 JPWO2022005807A5 JP2022581583A JP2022581583A JPWO2022005807A5 JP WO2022005807 A5 JPWO2022005807 A5 JP WO2022005807A5 JP 2022581583 A JP2022581583 A JP 2022581583A JP 2022581583 A JP2022581583 A JP 2022581583A JP WO2022005807 A5 JPWO2022005807 A5 JP WO2022005807A5
- Authority
- JP
- Japan
- Prior art keywords
- disease
- pharmaceutical composition
- compound
- disorder
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 208000014644 Brain disease Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000012377 drug delivery Methods 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000032382 Ischaemic stroke Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000018737 Parkinson disease Diseases 0.000 claims 1
- 230000008499 blood brain barrier function Effects 0.000 claims 1
- 210000001218 blood-brain barrier Anatomy 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- -1 carrier Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063047440P | 2020-07-02 | 2020-07-02 | |
| US63/047,440 | 2020-07-02 | ||
| PCT/US2021/038408 WO2022005807A1 (en) | 2020-07-02 | 2021-06-22 | Compounds for drug delivery across blood-brain barrier |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023532736A JP2023532736A (ja) | 2023-07-31 |
| JPWO2022005807A5 true JPWO2022005807A5 (https=) | 2024-06-27 |
| JP2023532736A5 JP2023532736A5 (https=) | 2024-06-27 |
Family
ID=77317394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022581583A Pending JP2023532736A (ja) | 2020-07-02 | 2021-06-22 | 血液脳関門を通過する薬物送達のための化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20230257420A1 (https=) |
| EP (1) | EP4175715A1 (https=) |
| JP (1) | JP2023532736A (https=) |
| CA (1) | CA3184089A1 (https=) |
| WO (1) | WO2022005807A1 (https=) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002359679B2 (en) * | 2001-12-11 | 2009-01-08 | Cellgate, Inc. | Guanidinium transport reagents and conjugates |
| US20180156826A1 (en) * | 2015-06-08 | 2018-06-07 | The Board Of Regents Of The University Of Texas Sy Stem | Compositions and methods for diagnosis of autism spectrum disorder |
| US10849875B2 (en) * | 2015-07-23 | 2020-12-01 | University Of Houston System | Cancer specific lipid targeted peptidomimetics |
-
2021
- 2021-06-22 JP JP2022581583A patent/JP2023532736A/ja active Pending
- 2021-06-22 US US18/011,649 patent/US20230257420A1/en active Pending
- 2021-06-22 WO PCT/US2021/038408 patent/WO2022005807A1/en not_active Ceased
- 2021-06-22 EP EP21754858.5A patent/EP4175715A1/en active Pending
- 2021-06-22 CA CA3184089A patent/CA3184089A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025013344A5 (https=) | ||
| JP2009500443A5 (https=) | ||
| JP2026035701A5 (https=) | ||
| JP2014502641A5 (https=) | ||
| JP2013500977A5 (https=) | ||
| JP2020520359A5 (https=) | ||
| JP2021534160A5 (https=) | ||
| JP2022501383A5 (https=) | ||
| JP2004536111A5 (https=) | ||
| DE60111520T2 (de) | Hydroxyphenyl-piperazinyl-methyl-benzamid-derivate zur schmerzbehandlung | |
| JPWO2022005807A5 (https=) | ||
| JP2025506252A (ja) | 鎮痛及び／又は鎮痒機能を有する医薬組成物及びその使用 | |
| JP2014534229A5 (https=) | ||
| CN116236490A (zh) | 脱氧胆酸的用途及药物 | |
| JPWO2020006233A5 (https=) | ||
| JPWO2020123449A5 (https=) | ||
| JP2021525758A5 (https=) | ||
| JP2017514829A5 (https=) | ||
| JPWO2023183943A5 (https=) | ||
| JPWO2023163203A5 (https=) | ||
| JPWO2023107938A5 (https=) | ||
| JPWO2020053377A5 (https=) | ||
| JP2021524855A5 (https=) | ||
| JP6862447B2 (ja) | ダニリキシンの静脈内注射用製剤 | |
| JPWO2021070054A5 (https=) |